The joint evaluation of the legislation on medicines for children and rare diseases (medicines for special populations – orphan medicines) is an important step in the process of assessing EU rules for these medical areas.
The 2017 Annual Transplant Report show that in 2017 there were 700 more transplants performed in the EU compared to the year before.
Director of Public Health at the Commission's Directorate-General for Health and Food Safety, John F. Ryan, discusses sustainable development goals on HIV/AIDS, viral hepatitis and tuberculosis and the Commission's work toward meeting them as reflected in the Staff Working Document published this summer.
By Vytenis Andriukaitis, Commissioner for Health and Food Safety
Deadline for submissions: 12 October 20h00 CET, Brussels time.
The Commission selected 11 initiatives as candidates for the 2018 EU Health Award for NGOs, which aims to reward Organisations that have contributed to a higher level of public health in the EU by working on preventing tobacco use.
On Friday 28 September, the Steering Group held an extraordinary meeting to discuss the current and future research programmes and other health investments as part of the next multiannual financial framework.
Interview of Jan De Maeseneer, Chair of the Expert Panel on effective ways of investing in health.
During the last three years, the Directive on Cross-border Healthcare (2011/24/EU) has proven to clarify and guarantee patients' rights to receive healthcare in another Member State, according to the latest implementation report the European Commission published today.
Head of Unit Pasi Pohjola and Dr Päivi Hämäläinen, a director and a project manager respectively at Finland's Ministry of Social Affairs and Health, discuss Finland’s recent participation in voluntary exchanges with the EU, the Organisation for Economic Co-operation and Development (OECD) and the European Observatory on Health Systems, which are open to every EU Member State through the State of Health in the EU initiative.